Bipolar Tied to a Sixfold Increased Risk of Early Death at AshTip Solution.

BORDEAUX, France — Could AEF0117, a drug that has a novel mechanism of action in the brain, be the drug to fight cannabis addiction? Results from a phase 2a clinical trial that examined the efficacy of AEF0117 in patients with cannabis use disorder have created quite a stir. The study was published in Nature Medicine. Not only did AEF0117 weaken the effects of cannabis, but it also decreased a person's desire to use it, all without causing withdrawal symptoms. These findings have generated a significant buzz in the scientific and medical community. 2023-06-23

Higher levels of alcohol consumption appear to increase an individual's risk of early-onset colorectal cancer (CRC), particularly distal colon and rectal cancers, according to a population-based study from Korea. 2023-07-07

An estimated 3 in every 10 white-tailed deer in the U.S. have had COVID-19, and new research suggests deer populations could be a source of virus mutations that may be passed to humans. 2023-07-12

Multiple gut bacterial species that are commonly found in the mouth, especially several forms of Streptococcus, were associated with coronary atherosclerosis and systemic inflammatory biomarkers in a population-based observational study. 2023-07-19

Stable patients who have a diagnostic cardiac catheterization for multivessel disease or two-vessel proximal left anterior descending disease often have percutaneous coronary intervention (PCI) in the same session, possibly without input from a multidisciplinary heart team, a new study suggests. 2023-07-25